Goals for rheumatoid arthritis: treating to target or treating to prevent?

Min Yang, Mingyang GuoRheumatology Center, PLA General Hospital of Chengdu Military Area Command, Chengdu, Sichuan Province, PR ChinaAlthough treat-to-target goals for rheumatoid arthritis (RA) have been well-established through several guidelines in recent years, concerns regarding treat-to-prevent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang M, Guo MY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/4e8ea355607f49929223c523b15f829c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Min Yang, Mingyang GuoRheumatology Center, PLA General Hospital of Chengdu Military Area Command, Chengdu, Sichuan Province, PR ChinaAlthough treat-to-target goals for rheumatoid arthritis (RA) have been well-established through several guidelines in recent years, concerns regarding treat-to-prevent goals for RA remain unclear. RA patients are typically subjected to over- or under-treatment because it is difficult for clinicians to determine the prognosis of RA patients. This typically results in failure to select and identify patient subsets that should receive monotherapy or combination therapy to treat early RA. Understanding treat-to-prevent goals, as well as unfavorable prognoses, risk factors, and prediction methods for RA, is therefore critical for making treatment decisions. Rapid radiographic progression plays a central role in contributing to other composite RA indices, so this may be the best method for defining treat-to-prevent goals for RA. Accordingly, risk factors of rapid radiographic progression have been defined and two prediction models were retrospectively derived based on clinical trial data. Additional studies are required to develop risk models that can be used for accurate predictions.Keywords: rapid radiographic progression, prognosis, risk factors, prediction models